Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.

Wessels D, Lusche DF, Voss E, Kuhl S, Buchele EC, Klemme MR, Russell KB, Ambrose J, Soll BA, Bossler A, Milhem M, Goldman C, Soll DR.

PLoS One. 2017 Mar 6;12(3):e0173400. doi: 10.1371/journal.pone.0173400. eCollection 2017.

2.

Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.

Daudigeos-Dubus E, Le Dret L, Lanvers-Kaminsky C, Bawa O, Opolon P, Vievard A, Villa I, Pagès M, Bosq J, Vassal G, Zopf D, Geoerger B.

PLoS One. 2015 Nov 23;10(11):e0142612. doi: 10.1371/journal.pone.0142612. eCollection 2015.

3.

Targeting the IGF-1R: The Tale of the Tortoise and the Hare.

Crudden C, Girnita A, Girnita L.

Front Endocrinol (Lausanne). 2015 Apr 27;6:64. doi: 10.3389/fendo.2015.00064. eCollection 2015. Review.

4.

Effect of epigallocatechin-3-gallate on proliferation and phenotype maintenance in rabbit articular chondrocytes in vitro.

Huang H, Liu Q, Liu L, Wu H, Zheng L.

Exp Ther Med. 2015 Jan;9(1):213-218. Epub 2014 Nov 10.

5.

Platelet-derived growth factor in glioblastoma-driver or biomarker?

Westermark B.

Ups J Med Sci. 2014 Nov;119(4):298-305. doi: 10.3109/03009734.2014.970304. Epub 2014 Oct 24. Review.

6.

Receptor tyrosine kinases: legacy of the first two decades.

Schlessinger J.

Cold Spring Harb Perspect Biol. 2014 Mar 1;6(3). pii: a008912. doi: 10.1101/cshperspect.a008912. Review.

7.

Targeting the PDGF signaling pathway in tumor treatment.

Heldin CH.

Cell Commun Signal. 2013 Dec 20;11:97. doi: 10.1186/1478-811X-11-97. Review.

8.

A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor.

Petti LM, Talbert-Slagle K, Hochstrasser ML, DiMaio D.

J Biol Chem. 2013 Sep 20;288(38):27273-86. doi: 10.1074/jbc.M113.470054. Epub 2013 Aug 1.

9.

Platelet-derived growth factors and their receptors: structural and functional perspectives.

Chen PH, Chen X, He X.

Biochim Biophys Acta. 2013 Oct;1834(10):2176-86. doi: 10.1016/j.bbapap.2012.10.015. Epub 2012 Nov 5. Review.

10.

Glioblastoma--a moving target.

Westermark B.

Ups J Med Sci. 2012 May;117(2):251-6. doi: 10.3109/03009734.2012.676574. Review.

11.

Autocrine PDGF stimulation in malignancies.

Heldin CH.

Ups J Med Sci. 2012 May;117(2):83-91. doi: 10.3109/03009734.2012.658119. Review.

12.

Safety of recombinant human platelet-derived growth factor-BB in Augment(®) Bone Graft.

Solchaga LA, Hee CK, Roach S, Snel LB.

J Tissue Eng. 2012;3(1):2041731412442668. doi: 10.1177/2041731412442668. Epub 2012 Apr 4.

13.

PDGF and PDGF receptors in glioma.

Nazarenko I, Hede SM, He X, Hedrén A, Thompson J, Lindström MS, Nistér M.

Ups J Med Sci. 2012 May;117(2):99-112. doi: 10.3109/03009734.2012.665097. Epub 2012 Apr 17. Review.

14.

Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis.

Demoulin JB, Montano-Almendras CP.

Am J Blood Res. 2012;2(1):44-56. Epub 2012 Jan 1.

15.

PDGF in gliomas: more than just a growth factor?

Lindberg N, Holland EC.

Ups J Med Sci. 2012 May;117(2):92-8. doi: 10.3109/03009734.2012.654860. Epub 2012 Feb 29.

16.

History of discovery: platelet-derived growth factor.

Bowen-Pope DF, Raines EW.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2397-401. doi: 10.1161/ATVBAHA.108.179556. Review.

17.

Platelet-derived growth factor receptor alpha in glioma: a bad seed.

Liu KW, Hu B, Cheng SY.

Chin J Cancer. 2011 Sep;30(9):590-602. doi: 10.5732/cjc.011.10236. Review.

18.

Platelet-derived growth factor signaling in human malignancies.

Liu KW, Hu B, Cheng SY.

Chin J Cancer. 2011 Sep;30(9):581-4. doi: 10.5732/cjc.011.10300.

19.

Cell signaling by receptor tyrosine kinases.

Lemmon MA, Schlessinger J.

Cell. 2010 Jun 25;141(7):1117-34. doi: 10.1016/j.cell.2010.06.011. Review.

20.

Roles for growth factors in cancer progression.

Witsch E, Sela M, Yarden Y.

Physiology (Bethesda). 2010 Apr;25(2):85-101. doi: 10.1152/physiol.00045.2009. Review.

Supplemental Content

Support Center